“…Their inclusion as the primary sample would likely improve the chances of causing and detecting related changes. Given the differences in prevalence of diseases known to impact cognitive function and the gut microbiome between ethnic/racial groups (e.g., dementia, hypertension, obesity, type 2 diabetes) [ 97 , 237 , 267 , 268 , 269 , 270 ], as well as evidence suggesting stable differences in gut microbiome composition due to geographic location and ethnicity/race [ 184 , 185 ], the recruitment of a diverse sample may aid examination of the potential effects of these respective factors on outcomes. Outcomes should include measures representative of the different pathways of the proposed mediation model, including cognitive function (i.e., cognitive testing, diagnosis of MCI, AD, VaD), indicators of brain health (e.g., BDNF, brain volume), indicators of disease [e.g., BMI, glucose, tumor necrosis factor-alpha (TNF-alpha)], and gut microbiome composition (i.e., DNA sequencing for amounts/proportions of gut microbiota).…”